<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00296647</url>
  </required_header>
  <id_info>
    <org_study_id>H-2004-0462</org_study_id>
    <secondary_id>P50DA019706</secondary_id>
    <nct_id>NCT00296647</nct_id>
    <nct_alias>NCT00106873</nct_alias>
  </id_info>
  <brief_title>Smoking Cessation Intervention: Effectiveness in Primary Care</brief_title>
  <official_title>Tobacco Dependence: Treatment and Outcomes; Pharmacotherapies: Effectiveness in Primary Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Wisconsin, Madison</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The information gathered in this study may help to develop more effective ways to help people
      quit smoking and stay quit in the future.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized clinical trials may not accurately reflect the public health benefit of tobacco
      dependence pharmacotherapies when used in real-world clinical settings due to differences in
      patient selection, motivation, and adherence. To have a positive public health impact, a
      treatment must be accessible and acceptable to a broad range of smokers and effective under
      normal use conditions. The proposed project will assess primary care patients willingness to
      use cessation treatment and will determine the relative effectiveness of five cessation
      pharmacotherapies. This research builds on a primary care clinic-based recruitment strategy
      that was highly successful in a previous study. In the proposed research, 1320 primary care
      patients presenting for a regular outpatient visit will be recruited by medical assistants to
      participate in a free smoking cessation program and will be randomly assigned to one of five
      active pharmacotherapies: patch, lozenge, bupropion, patch+lozenge, and bupropion+lozenge (n
      = 264/condition). Interested participants who pass medical screening will pick up their
      medications at clinic pharmacies and will receive proactive telephone counseling from the
      Wisconsin Tobacco Quit Line. Assessment will be limited to preserve the generalizability of
      the findings, but select individual differences will be assessed pre-quit to validate
      algorithms (from Project 1: Efficacy) designed to optimize pharmacotherapy selection for
      smokers based on gender, level of dependence, and other factors. Smoking behavior will be
      assessed at six months and one year post-quit so that abstinence rates across pharmacotherapy
      conditions can be compared. The cost of incorporating tobacco dependence treatment into
      primary care will also be estimated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2004</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>6 Month Self-reported Abstinence From Smoking</measure>
    <time_frame>6 months</time_frame>
    <description>Primary postquit outcomes was 7-day point prevalence abstinence (0, abstinent; 1, smoking) at 6 months (based on the week 24 interview)</description>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">1346</enrollment>
  <condition>Tobacco Dependence</condition>
  <arm_group>
    <arm_group_label>patch</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>nicotine lozenge</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>bupropion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>patch + lozenge</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>buproion + lozenge</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nicotine patch</intervention_name>
    <description>Decreasing dosages from 21 to 7 mg over 12 week period</description>
    <arm_group_label>patch</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nicotine patch</intervention_name>
    <description>Decreasing dosage from 21 to 7 mg over 12 weeks</description>
    <arm_group_label>patch</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nicotine lozenge</intervention_name>
    <description>4 mg nicotine lozenge: dosage according to package directions for 16 weeks</description>
    <arm_group_label>nicotine lozenge</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupropion</intervention_name>
    <description>dosage according to prescription directions: 12 weeks</description>
    <arm_group_label>bupropion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>patch + lozenge</intervention_name>
    <description>dosage of each according to package insert directions (12 weeks patch, 16 weeks lozenge)</description>
    <arm_group_label>patch + lozenge</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupropion + lozenge</intervention_name>
    <description>dosage of each according to prescription or package insert (12 weeks bupropion, 16 weeks lozenge)</description>
    <arm_group_label>buproion + lozenge</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Smoke at least 10 cigarettes per day for the previous 6 months - Expired CO &gt; 9 ppm -
             Motivated to quit smoking - Able to read and write English - Willing to complete
             required study assessments, Aurora participating clinic patient

        Exclusion Criteria:

          -  Uncontrolled hypertension (systolic &gt;180mm Hg or diastolic &gt;110mm Hg) - History of
             bipolar disorder or psychosis - Myocardial infarction or other serious cardiac problem
             in the previous 4 weeks - History of diagnosed anorexia and/or bulimia - Diagnosis of
             Alcohol Dependence in the previous 6 months by participant self-report or drinking 6
             or more drinks on six or more days a week - History of seizure and/or serious head
             injury involving loss of consciousness - Use of contraindicated medications (MAO
             inhibitors, bupropion, lithium, anticonvulsants, antipsychotics) - Currently pregnant
             or breast-feeding - Unwilling to use effective contraception during the treatment
             phase - More than one participant from the same household - Allergic reactions to 3 or
             more classes of drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas C Jackson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aurora Health Care</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UW-CTRI Milwaukee Research site</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.ctri.wisc.edu</url>
    <description>web site of the study lead investigators</description>
  </link>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2006</study_first_submitted>
  <study_first_submitted_qc>February 24, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2006</study_first_posted>
  <results_first_submitted>October 21, 2011</results_first_submitted>
  <results_first_submitted_qc>October 21, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 30, 2011</results_first_posted>
  <last_update_submitted>October 9, 2015</last_update_submitted>
  <last_update_submitted_qc>October 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
    <mesh_term>Bupropion</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were 1346 smokers recruited in 12 Aurora Health Care primary care clinics in eastern Wisconsin from October 2005 through May 2007.</recruitment_details>
      <pre_assignment_details>Primary inclusion criteria included (1) 18 years or older; (2) 10 or more cigarettes per day (CPD) for the past 6 months; (3) motivated to quit smoking; and (4) if female, willing to use an acceptable contraception while using the study medication.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Patch</title>
        </group>
        <group group_id="P2">
          <title>Nicotine Lozenge</title>
        </group>
        <group group_id="P3">
          <title>Bupropion</title>
        </group>
        <group group_id="P4">
          <title>Patch + Lozenge</title>
        </group>
        <group group_id="P5">
          <title>Buproion + Lozenge</title>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="282"/>
                <participants group_id="P2" count="261"/>
                <participants group_id="P3" count="256"/>
                <participants group_id="P4" count="279"/>
                <participants group_id="P5" count="268"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="250"/>
                <participants group_id="P2" count="233"/>
                <participants group_id="P3" count="222"/>
                <participants group_id="P4" count="262"/>
                <participants group_id="P5" count="248"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="28"/>
                <participants group_id="P3" count="34"/>
                <participants group_id="P4" count="17"/>
                <participants group_id="P5" count="20"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="27"/>
                <participants group_id="P3" count="32"/>
                <participants group_id="P4" count="16"/>
                <participants group_id="P5" count="19"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Patch</title>
        </group>
        <group group_id="B2">
          <title>Nicotine Lozenge</title>
        </group>
        <group group_id="B3">
          <title>Bupropion</title>
        </group>
        <group group_id="B4">
          <title>Patch + Lozenge</title>
        </group>
        <group group_id="B5">
          <title>Buproion + Lozenge</title>
        </group>
        <group group_id="B6">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="282"/>
            <count group_id="B2" value="261"/>
            <count group_id="B3" value="256"/>
            <count group_id="B4" value="279"/>
            <count group_id="B5" value="268"/>
            <count group_id="B6" value="1346"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44.5" spread="12.4"/>
                    <measurement group_id="B2" value="42.9" spread="11.7"/>
                    <measurement group_id="B3" value="44" spread="11.6"/>
                    <measurement group_id="B4" value="44.8" spread="12.4"/>
                    <measurement group_id="B5" value="45.4" spread="12.2"/>
                    <measurement group_id="B6" value="44.3" spread="12.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="158"/>
                    <measurement group_id="B2" value="142"/>
                    <measurement group_id="B3" value="143"/>
                    <measurement group_id="B4" value="158"/>
                    <measurement group_id="B5" value="152"/>
                    <measurement group_id="B6" value="753"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="124"/>
                    <measurement group_id="B2" value="119"/>
                    <measurement group_id="B3" value="113"/>
                    <measurement group_id="B4" value="121"/>
                    <measurement group_id="B5" value="116"/>
                    <measurement group_id="B6" value="593"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="282"/>
                    <measurement group_id="B2" value="261"/>
                    <measurement group_id="B3" value="256"/>
                    <measurement group_id="B4" value="279"/>
                    <measurement group_id="B5" value="268"/>
                    <measurement group_id="B6" value="1346"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>6 Month Self-reported Abstinence From Smoking</title>
        <description>Primary postquit outcomes was 7-day point prevalence abstinence (0, abstinent; 1, smoking) at 6 months (based on the week 24 interview)</description>
        <time_frame>6 months</time_frame>
        <population>intent to treat</population>
        <group_list>
          <group group_id="O1">
            <title>Patch</title>
          </group>
          <group group_id="O2">
            <title>Lozenge</title>
          </group>
          <group group_id="O3">
            <title>Bupropion</title>
          </group>
          <group group_id="O4">
            <title>Patch + Lozenge</title>
          </group>
          <group group_id="O5">
            <title>Buproion + Lozenge</title>
          </group>
        </group_list>
        <measure>
          <title>6 Month Self-reported Abstinence From Smoking</title>
          <description>Primary postquit outcomes was 7-day point prevalence abstinence (0, abstinent; 1, smoking) at 6 months (based on the week 24 interview)</description>
          <population>intent to treat</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="279"/>
                <count group_id="O2" value="261"/>
                <count group_id="O3" value="256"/>
                <count group_id="O4" value="279"/>
                <count group_id="O5" value="268"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="52"/>
                    <measurement group_id="O3" value="45"/>
                    <measurement group_id="O4" value="75"/>
                    <measurement group_id="O5" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months collection at scheduled follow up time points</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Patch</title>
        </group>
        <group group_id="E2">
          <title>Nicotine Lozenge</title>
        </group>
        <group group_id="E3">
          <title>Bupropion</title>
        </group>
        <group group_id="E4">
          <title>Patch + Lozenge</title>
        </group>
        <group group_id="E5">
          <title>Buproion + Lozenge</title>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="282"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="261"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="256"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="279"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="268"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>death</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="282"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="261"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="256"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="279"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="268"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="282"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="261"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="256"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="279"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="268"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>nausea</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="282"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="261"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="256"/>
                <counts group_id="E4" events="8" subjects_affected="8" subjects_at_risk="279"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="268"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>skin irritation</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="282"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="261"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="256"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="279"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="268"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The present study is limited to some extent by the fact that self-reported abstinence was not biochemically confirmed. However, there is evidence that self-reported abstinence rates are generally accurate in low-contact effectiveness studies.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Stevens Smith, PhD</name_or_title>
      <organization>UW-Center for Tobacco Research and Intervention</organization>
      <phone>608-262-7563</phone>
      <email>sss@ctri.medicine.wisc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

